Harbin Pharmaceutical Group and its subsidiary Harbin Pharmaceutical
Co., Ltd. held the pro-seminar entitled "the capital market
and product market for Harbin Pharmaceutical Group" in
Shanghai on December 10. It was revealed that the company endeavors
to become one of the 50 biggest profit-making pharmaceutical
enterprises in the world during the 10th five-year plan period.
The goals for Harbin
Pharmaceutical Group during the tenth five-year plan are to
adjust its capital structure, to make two of its subsidiaries
listed on the domestic and overseas stock markets, to make
technological innovations, and to build up six production
bases in order to make itself one of the 50 biggest profit-making
pharmaceutical enterprises in the world, as was reported.
(People's Daily
12/12/2000)
|
